Molecular mechanisms of glucocorticoids action: implications for treatment of rhinosinusitis and nasal polyposis
Open Access
- 14 July 2010
- journal article
- research article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 268 (2) , 247-253
Abstract
Intra-nasal glucocorticoids are the most effective drugs available for rhinosinusitis and nasal polyposis treatment. Their effectiveness depends on many factors and not all of them have been well recognized so far. The authors present the basic information on molecular mechanisms of glucocorticoid action, direct and indirect effects of glucocorticoids on transcription of genes encoding inflammatory mediators. They focus on recently proved nongenomic mechanisms which appear quickly, from several seconds to minutes after glucocorticoid administration and discuss clinical implications resulting from this knowledge. Discovery of nongenomic glucocorticoid actions allows for better use of these drugs in clinical practice.Keywords
This publication has 44 references indexed in Scilit:
- Treatment of congestion in upper respiratory diseasesInternational Journal of General Medicine, 2010
- Vascular Endothelial Growth Factor Drives Autocrine Epithelial Cell Proliferation and Survival in Chronic Rhinosinusitis with Nasal PolyposisAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Dynamic access of the glucocorticoid receptor to response elements in chromatinThe International Journal of Biochemistry & Cell Biology, 2009
- The diagnosis and management of rhinitis: An updated practice parameterJournal of Allergy and Clinical Immunology, 2008
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*Allergy, 2008
- BSACI guidelines for the management of rhinosinusitis and nasal polyposisClinical & Experimental Allergy, 2007
- How corticosteroids control inflammation: Quintiles Prize Lecture 2005British Journal of Pharmacology, 2006
- Vascular endothelial growth factor–mediated induction of angiogenesis by human rhinovirusesJournal of Allergy and Clinical Immunology, 2006
- Intranasal fluticasone propionate is effective for perennial nonallergic rhinitis with or without eosinophiliaAnnals of Allergy, Asthma & Immunology, 2002
- Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanismBritish Journal of Pharmacology, 2000